MATTHEW WEISSLER, M.D.
Hematology & Oncology Physician · WHITE PLAINS, NY
Individual Active NPI 1528225695
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 628 | 340,617.5 | $13,758,598 | $5,490,899 | $4,367,607 |
| 2023 | 741 | 349,203 | $14,194,103 | $5,256,092 | $4,188,054 |
| 2022 | 746 | 362,633 | $14,881,076 | $5,673,882 | $4,521,560 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 86,250 | $1 | $1 |
| J9271 | Injection, pembrolizumab, 1 mg | 21,800 | $56 | $45 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 20,600 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 13,650 | $0 | $0 |
| J1756 | Injection, iron sucrose, 1 mg | 8,800 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 8,340 | $26 | $21 |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 5,669 | $26 | $21 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 4,368 | $0 | $0 |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 3,460 | $7 | $6 |
| J0640 | Injection, leucovorin calcium, per 50 mg | 2,484 | $4 | $4 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,252 | $0 | $0 |
| J9190 | Injection, fluorouracil, 500 mg | 1,680.5 | $3 | $2 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 235558 | NY |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in New York
- NPI 1144240680
- NPI 1396087888
- NPI 1174998249
- NPI 1083600266
- NPI 1033103155
- NPI 1336266972
- NPI 1578559910
- NPI 1609251123
See all Hematology & Oncology Physician providers in New York →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.